DMK PHARMACEUTICALS CORPORATION: cashflow_financing
| Value | {"amount": 20020986, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-09-30 |
| Status | current |
| Entity | DMK PHARMACEUTICALS CORPORATION |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e49af8da-293e-4191-a31a-1d3c80cef43e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001387131-20-009722 · Open the official SEC filing →Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000887247/cashflow-financing/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e49af8da-293e-4191-a31a-1d3c80cef43e
History
- no predecessors — first report